Bulk Manufacturer of Controlled Substances Application: Patheon API Manufacturing, Inc., 26070-26071 [2021-09988]
Download as PDF
<![CDATA[
26070
Federal Register / Vol. 86, No. 90 / Wednesday, May 12, 2021 / Notices
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed collection OMB 1140–
0072 (Explosives Employee Possessor
Questionnaire—ATF Form 5400.28) is
being revised to include additional
questions, and a new format and layout
to improve user experience. This
collection is also being published to
obtain comments from the public and
affected agencies.
DATES: Comments are encouraged and
will be accepted for 60 days until July
12, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments,
regarding the estimated public burden
or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions, or
additional information, please contact:
Shawn Stevens, Federal Explosives
Licensing Center either by mail at 44
Needy Road, Martinsburg, WV 25405,
by email at Shawn.Stevens@atf.gov, or
by telephone at 304–616–4400.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so, how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection
(check justification or form 83):
Revision of a currently approved
collection.
2. The Title of the Form/Collection:
Explosives Employee Possessor
Questionnaire.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): ATF
Form 5400.28.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Individuals or households.
Other (if applicable): Business or
other for-profit.
Abstract: The Explosives Employee
Possessor Questionnaire—ATF Form
5400.28 will be used to determine if an
individual is qualified to serve as an
employee possessor, who can ship,
transport, receive, and/or possess
materials for an explosives business or
operation.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 10,000
respondents will use the form annually,
and it will take each respondent
approximately 20 minutes to complete
their responses.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
3,334 hours, which is equal to 10,000 (#
of respondents) * .3333 (20 minutes).
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
Dated: May 7, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2021–10005 Filed 5–11–21; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–826]
Bulk Manufacturer of Controlled
Substances Application: Patheon API
Manufacturing, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Patheon API Manufacturing,
Inc., has applied to be registered as a
bulk manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 12, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 12, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 18, 2021,
Patheon API Manufacturing, Inc., 309
Delaware Street, Greenville, South
Carolina 29605–5420, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
5-Methoxy-N-N-Dimethyltryptamine ................................................................................................................................
a-Methyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
VerDate Sep<11>2014
17:58 May 11, 2021
Jkt 253001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
E:\FR\FM\12MYN1.SGM
12MYN1
2010
7370
7431
7432
7437
9333
9652
9668
Schedule
I
I
I
I
I
II
II
II
Federal Register / Vol. 86, No. 90 / Wednesday, May 12, 2021 / Notices
The company plans to bulk
manufacture the listed controlled
substances as an Active Pharmaceutical
Ingredient (API) for distribution to its
customers. In reference to dug code
7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture this
drug as synthetic. No other activities for
these drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
Revenue Service’s (IRS) Statistics of
Income (SOI) Annual Individual Income
Tax ZIP Code Data, and the U.S.
Securities and Exchange Commission’s
(SEC) Electronic Data Gathering,
Analysis, and Retrieval (EDGAR)
System.
FOR FURTHER INFORMATION CONTACT:
Regina Kearney at the OMB Office of
Federal Financial Management at (202)
395–3993.
Shalanda Young,
Acting Director.
[FR Doc. 2021–09988 Filed 5–11–21; 8:45 am]
BILLING CODE P
[FR Doc. 2021–10025 Filed 5–11–21; 8:45 am]
BILLING CODE 3110–01–P
AGENCY:
The Payment Integrity
Information Act of 2019 (PIIA)
authorizes the Office of Management
and Budget (OMB) to designate
databases for inclusion in Treasury’s
Working System under the Do Not Pay
(DNP) Initiative. PIIA further requires
OMB to provide public notice and
opportunity for comment prior to
designating additional databases. In
fulfillment of this requirement, on
January 22, 2021, OMB published a
Notice of Proposed Designation for 12
additional databases. OMB received one
comment during the 30-day comment
period for this notice; however, the
suggestions found therein did not
preclude further action for the formal
designation of the databases into
Treasury’s Working System. Effective
immediately, OMB designates the
following 12 databases: The United
States Postal Service (USPS) Delivery
Sequence File, the Census Bureau
Federal Audit Clearinghouse, the Do
Not Pay (DNP) Agency Adjudication
Data, Fiscal Service’s Payments, Claims,
and Enhanced Reconciliation (PACER)
database, Bureau of Prisons (BOP)
Incarceration Data, Digital
Accountability and Transparency Act
(DATA Act) data, Census Bureau’s
American Communities Survey (ACS)
Annual State and County Data Profiles,
Veterans Affairs’ (VA) Beneficiary
Identification Records Locator Service
(BIRLS), Department of Agriculture’s
National Disqualified List (NDL), Center
for Medicare and Medicaid Services
(CMS) National Plan and Provider
Enumeration System (NPPES), Internal
In accordance with the Federal
Advisory Committee Act (Pub. L. 92–
463, as amended), the National Science
Foundation (NSF) announces the
following meeting:
Name and Committee Code:
Committee on Equal Opportunities in
Science and Engineering (CEOSE)
Virtual Meeting (1173).
Date and Time: June 10, 2021; 1:00
p.m.–5:30 p.m.; June 11, 2021; 10:00
a.m.–3:30 p.m.
Place: National Science Foundation,
2415 Eisenhower Avenue, Alexandria,
VA 22314 (Virtual). Meeting
Registration: Virtual attendance
information will be forthcoming on the
CEOSE website at https://www.nsf.gov/
od/oia/activities/ceose/index.jsp.
Type of Meeting: Open.
Contact Person: Dr. Bernice
Anderson, Senior Advisor and CEOSE
Executive Secretary, Office of
Integrative Activities (OIA), National
Science Foundation, 2415 Eisenhower
Avenue, Alexandria, VA 22314. Contact
Information: 703–292–8040/banderso@
nsf.gov.
Minutes: Meeting minutes and other
information may be obtained from the
CEOSE Executive Secretary at the above
address or the website at https://
www.nsf.gov/od/oia/activities/ceose/
index.jsp.
Purpose of Meeting: To study data,
programs, policies, and other
information pertinent to the National
Science Foundation and to provide
advice and recommendations
concerning broadening participation in
science and engineering.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
NATIONAL SCIENCE FOUNDATION
Committee on Equal Opportunities in
Science and Engineering; Notice of
Meeting
Office of Management and
Budget.
ACTION: Notice of designation.
VerDate Sep<11>2014
17:58 May 11, 2021
Jkt 253001
PO 00000
Frm 00074
Fmt 4703
Agenda
Day 1: June 10, 2021
• Welcome, Introductions, Opening
Remarks
• Report of the CEOSE Executive
Liaison
• Presentation: Missing Millions and
NSF Efforts
• Joint Session with NSB [Focus on
STEM Technical Careers]
• Discussion with NSF Director and
Chief Operating Officer
• CEOSE Liaison Reports
• Working Session: DCL and Flyer for
the 2019–2020 CEOSE Report
Day 2: June 11, 2021
OFFICE OF MANAGEMENT AND
BUDGET
Designation of Databases for
Treasury’s Working System Under the
Do Not Pay Initiative
26071
Sfmt 4703
• Welcome and Remarks about
Subcommittee: The Future of EPSCoR
• BP Accountability Data
• Presentation: Broadening
Participation Research
• Reports of the Federal Liaisons
• Presentation: NSF’s Racial Equity
Task Force
• Reports of the CEOSE Liaisons
• Announcements, Closing Remarks,
and Adjournment
Dated: May 7, 2021.
Crystal Robinson,
Committee Management Officer.
[FR Doc. 2021–10033 Filed 5–11–21; 8:45 am]
BILLING CODE 7555–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2021–0001]
Sunshine Act Meetings
Weeks of May 17, 24, 31,
June 7, 14, 21, 2021.
PLACE: Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public.
MATTERS TO BE CONSIDERED:
TIME AND DATE:
Week of May 17, 2021
Monday, May 17, 2021
3:00 p.m.—Affirmation Session (Public
Meeting) (Tentative), Direct Final
Rule: Advanced Boiling Water
Reactor Design Certification
Renewal (RIN 3150–AK04; NRC–
2017–0090) (Tentative) (Contact:
Wesley Held: 301–287–3591)
Additional Information: Due to
COVID–19, there will be no physical
public attendance. The public is invited
to attend the Commission’s meeting
live; via teleconference. Details for
joining the teleconference in listen only
mode may be found at https://
www.nrc.gov/pmns/mtg.
E:\FR\FM\12MYN1.SGM
12MYN1
]]>Agencies
[Federal Register Volume 86, Number 90 (Wednesday, May 12, 2021)]
[Notices]
[Pages 26070-26071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09988]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-826]
Bulk Manufacturer of Controlled Substances Application: Patheon
API Manufacturing, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Patheon API Manufacturing, Inc., has applied to be registered
as a bulk manufacturer of basic class(es) of controlled substance(s).
Refer to Supplementary Information listed below for further drug
information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before July 12, 2021.
Such persons may also file a written request for a hearing on the
application on or before July 12, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 18, 2021, Patheon API Manufacturing, Inc., 309
Delaware Street, Greenville, South Carolina 29605-5420, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.......... 2010 I
Tetrahydrocannabinols.............. 7370 I
5-Methoxy-N-N-Dimethyltryptamine... 7431 I
a-Methyltryptamine................. 7432 I
Psilocybin......................... 7437 I
Thebaine........................... 9333 II
Oxymorphone........................ 9652 II
Noroxymorphone..................... 9668 II
------------------------------------------------------------------------
[[Page 26071]]
The company plans to bulk manufacture the listed controlled
substances as an Active Pharmaceutical Ingredient (API) for
distribution to its customers. In reference to dug code 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture this
drug as synthetic. No other activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-09988 Filed 5-11-21; 8:45 am]
BILLING CODE P
